EFFICACY OF KEMRON (LOW-DOSE ORAL NATURAL HUMAN INTERFERON-ALPHA) IN THE MANAGEMENT OF HIV-1 INFECTION AND ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS)

被引：0
|
作者：
KOECH, DK
OBEL, AO
机构：
来源：
EAST AFRICAN MEDICAL JOURNAL | 1990年 / 67卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：SS64 / SS70
页数：7
相关论文
共 38 条
  • [21] ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME OCCURRING WITHIN 5 YEARS OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 - THE MULTICENTER AIDS COHORT STUDY
    PHAIR, J
    JACOBSON, L
    DETELS, R
    RINALDO, C
    SAAH, A
    SCHRAGER, L
    MUNOZ, A
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1992, 5 (05) : 490 - 496
  • [22] AN HISTORICAL-PERSPECTIVE ON THE EPIDEMIC OF HUMAN T-LEUKEMIA VIRUS (HTLV-III) INFECTION AND THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS)
    MORTON, RS
    EUROPEAN JOURNAL OF SEXUALLY TRANSMITTED DISEASES, 1986, 3 (03): : 115 - 119
  • [23] Lack of efficacy of low dose oral interferon alfa in symptomatic HIV-1 infection: a randomised, double blind, placebo controlled trial
    Katabira, ET
    Sewankambo, NK
    Mugerwa, RD
    Belsey, EM
    Mubiru, FX
    Othieno, C
    Kataaha, P
    Karam, M
    Youle, M
    Perriens, JH
    Lange, JMA
    SEXUALLY TRANSMITTED INFECTIONS, 1998, 74 (04) : 265 - 270
  • [24] A Double-Blind Randomized Controlled Study to Evaluate the Efficacy of Low-Dose Oral Interferon-Alpha in Preventing Hepatitis C Relapse
    Lee, Chuan-Mo
    Chen, Chi-Yi
    Chien, Rong-Nan
    Tseng, Kuo-Chih
    Peng, Cheng-Yuan
    Tung, Shui-Yi
    Fang, Yi-Jen
    Huang, Yi-Hsiang
    Lu, Sheng-Nan
    Hung, Chao-Hung
    Tsai, Tsung-Jang
    Fang, Chien-Chung
    Hsu, Chao-Wei
    Yeh, Chau-Ting
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2014, 34 (03): : 187 - 194
  • [25] INCREASED EFFICACY OF HUMAN NATURAL INTERFERON-ALPHA (IFN-ALPHA-N3) VERSUS HUMAN RECOMBINANT IFN-ALPHA-2 FOR INHIBITION OF HIV-1 REPLICATION IN PRIMARY HUMAN MONOCYTES
    FAN, SX
    SKILLMAN, DR
    LIAO, MJ
    TESTA, D
    MELTZER, MS
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (11) : 1115 - 1122
  • [26] CHEMOTHERAPY OF THE ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS) - NONNUCLEOSIDE INHIBITORS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 : 83 - 89
  • [27] Genetic predisposition to HIV-1 infection and acquired immune deficiency virus syndrome - A review of the literature examining associations with HLA
    Just, JJ
    HUMAN IMMUNOLOGY, 1995, 44 (03) : 156 - 169
  • [28] RECOMBINANT INTERLEUKIN-2 (RIL-2) IN ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME (AIDS) - PRELIMINARY-REPORT IN PATIENTS WITH LYMPHOMA ASSOCIATED WITH HIV-INFECTION
    MAZZA, P
    BOCCHIA, M
    TUMIETTO, F
    COSTIGLIOLA, P
    CORONADO, O
    BANDINI, G
    CONTE, R
    RICCHI, E
    VIANELLI, N
    RAISE, E
    FONDACARO, A
    RE, MC
    VIGNOLI, M
    CHIODO, F
    TURA, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1992, 49 (01) : 1 - 6
  • [29] Low dose oral interferon alpha 2a in HIV-1 seropositive patients: A double-blind, placebo-controlled trial
    Wright, SE
    Hutcheson, DP
    Cummins, JM
    BIOTHERAPY, 1998, 11 (04) : 229 - 234
  • [30] EFFICACY, SAFETY, AND TOLERANCE OF LOW-DOSE, LONG-TERM INTERFERON-ALPHA(2B) AND ZIDOVUDINE IN EARLY-STAGE AIDS-ASSOCIATED KAPOSIS-SARCOMA
    MAUSS, S
    JABLONOWSKI, H
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 (02): : 157 - 162
1234